24-month outcomes in the EVOLUTION study: Investigating the iVolution stent in femoropopliteal lesions

Investigating the iVolution 3rd generation nitinol stent in TASC A&B femoropopliteal lesions : 24-month outcomes in the EVOLUTION study, first presented at LINC 2019.